As of 2025-07-11, the Intrinsic Value of Landos Biopharma Inc (LABP) is -39.61 USD. This LABP valuation is based on the model Peter Lynch Fair Value. With the current market price of 22.93 USD, the upside of Landos Biopharma Inc is -272.74%.
Based on its market price of 22.93 USD and our intrinsic valuation, Landos Biopharma Inc (LABP) is overvalued by 272.74%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -39.61 - -39.61 | -39.61 | -272.74% |
| P/E | (122.47) - (137.84) | (132.89) | -679.6% |
| DDM - Stable | (60.67) - (170.77) | (115.72) | -604.7% |
| DDM - Multi | (46.88) - (104.80) | (65.03) | -383.6% |
| Market Cap (mil) | 71.77 |
| Beta | 0.70 |
| Outstanding shares (mil) | 3.13 |
| Enterprise Value (mil) | 42.77 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.66% |
| Cost of Debt | 5.00% |
| WACC | 7.16% |